Hot Life Science Investor Mandate 3: Corporate VC of Large French Corporation Seeking Early Stage Device and HIT Opportunities

4 Dec

The corporate Venture Capital Arm of a French Medical Gas company is currently seeking to make new investments in the life science space. The firm is open to leading or co-investing with other investors and typical allocations are made in equity ranging from €1-10 million. The firm is currently seeking new opportunities across a wide geography, including Western Europe, North and South America and Asia.

The firm focuses on medical devices and health IT products that present novel treatment, monitoring, or self-care strategies in either hospital or home settings. In general, the firm is interested in chronic diseases, particularly in COPD, sleep apnea, renal diseases, and Parkinson’s disease. The technology should complement its current portfolio and fit the firms long-term goals. The firm specializes in early stage projects from concept to clinical development.

The firm is looking for competent management teams with some previous experience in taking a company to an exit and understanding of the negotiations throughout the process. The firm typically takes a board seat in the companies it invests in.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: